Table 7 Distribution of TLR4 combined genotypes in vitiligo patients and healthy controls

COMBINED

CCCCAG

1

1

1.00 (0.16–16.21)

1.00/NS

CCCTAA

2

1

2.02 (0.18–22.04)

0.57/NS

CCCTAG

6

2

3.13 (0.62–15.89)

0.17/NS

CCCTGG

1

1

1.00 (0.16–16.21)

1.00/NS

CTCCAA

1

2

0.49 (0.04–5.55)

0.57/NS

CTCCAG

2

4

0.49 (0.09–2.74)

0.42/NS

CTCTAA

2

3

0.66 (0.11–4.03)

0.65/NS

CTCTAG

6

9

0.65 (0.22–1.89)

0.42/NS

CTCTGG

1

3

0.33 (0.03–3.19)

0.34/NS

CTTTAA

1

1

1.00 (0.16–16.21)

1.00/NS

CTTTAG

2

2

1.00 (0.14 –7.24)

1.00/NS

TTCCAA

3

5

0.59 (0.14–2.53)

0.48/NS

TTCCAG

8

11

0.70 (0.27–1.83)

0.74/NS

TTCCGG

2

3

0.66 (0.11–4.03)

0.65/NS

TTCTAA

11

10

1.11 (0.45–2.75)

0.82/NS

TTCTAG

29

23

1.34 (0.72–2.85)

0.33/NS

TTCTGG

8

7

1.16 (0.40–3.32)

0.79/NS

TTTTAA

3

2

1.52 (0.25–9.27)

0.65/NS

TTTTAG

8

5

1.65 (0.52–5.24)

0.39/NS

TTTTGG

2

2

1.00 (0.14–7.24)

1.00/NS